Minimally Invasive Surgical Devices Market to Reach USD 53.26 Billion by 2034, Growing at 7.13% CAGR

Leading minimally invasive surgical devices companies include Abbott, Olympus, Intuitive Surgical Inc., Stryker, and more

Mar. 10, 2026 at 10:21pm

Got story updates? Submit your updates here. ›

The global minimally invasive surgical devices market is projected to grow from USD 30,798.01 million in 2025 to USD 53,259.85 million by 2034, registering a CAGR of 7.13% during the forecast period. The market growth is driven by the increasing prevalence of chronic diseases, adoption of advanced surgical technologies, and rising patient preference for faster recovery procedures.

Why it matters

The growing burden of chronic diseases, such as cancer, cardiovascular disorders, diabetes, and obesity, is a key factor driving the demand for minimally invasive surgical procedures. These procedures offer clinical and economic advantages over traditional open surgeries, including reduced postoperative pain, shorter hospital stays, and lower infection risks.

The details

Minimally invasive surgical (MIS) devices enable surgical procedures to be performed through small incisions or natural body openings, minimizing trauma to surrounding tissues. These devices include laparoscopes, endoscopes, robotic surgical platforms, and advanced electrosurgical tools. Technological advancements, such as the integration of robotic-assisted surgical systems, AI-powered imaging, and augmented reality tools, are transforming surgical care and improving patient outcomes.

  • In March 2024, Intuitive Surgical received FDA 510(k) clearance for the da Vinci 5 system, the latest generation of its robotic surgical platform.
  • In April 2025, CardioVia's ViaOne System received FDA clearance, enabling safer access to the pericardial space for diagnostic and therapeutic cardiac procedures.
  • In 2024, Virtual Incision's MIRA Surgical System received FDA marketing authorization for adult colectomy procedures, representing one of the first miniaturized robotic surgical platforms.

The players

Abbott

A global healthcare company that develops medical devices, including minimally invasive surgical technologies.

Olympus Corporation

A Japanese multinational corporation that manufactures medical devices, including endoscopes and other minimally invasive surgical instruments.

Intuitive Surgical Inc.

An American company that develops and manufactures robotic-assisted surgical systems, such as the da Vinci Surgical System.

Stryker

An American multinational medical technology company that produces a wide range of medical devices, including minimally invasive surgical tools.

Johnson & Johnson Medical Devices Companies

A division of Johnson & Johnson that develops and manufactures a variety of medical devices, including minimally invasive surgical products.

Got photos? Submit your photos here. ›

What’s next

The future of the minimally invasive surgical devices market appears highly promising as robotics, artificial intelligence, and advanced imaging technologies continue to reshape modern surgical practices. The growing adoption of AI-driven surgical systems, augmented reality navigation platforms, and data-driven surgical planning tools will further expand the capabilities of minimally invasive procedures.

The takeaway

The minimally invasive surgical devices market is poised for significant growth, driven by the increasing prevalence of chronic diseases, technological advancements, and rising patient demand for less invasive surgical options. As healthcare providers prioritize patient-centric and cost-effective solutions, minimally invasive technologies are expected to play a crucial role in the future of surgical care.